Natdac (DAKLINZA) Daclatasvir 60mg online


In stock


Natdac (Daclatasvir 60mg)is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use:
1.Sustainedvirologicresponse(SVR12)ratesarereducedingenotype3patientswith cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.

Submit your review

Your email address will not be published. Required fields are marked *


There are no reviews yet.

See It Styled On Instagram

    Instagram did not return any images.

Main Menu